The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Serum anti-Mullerian hormone throughout the human menstrual cycle
Open accessAbstract
BACKGROUND: The anti-Mullerian hormone (AMH) is a member of the transforming growth factor (TGF) superfamily. In women, AMH serum levels can be almost undetectable at birth, with a subtle increase noted after puberty. Data are lacking with regard to menstrual cycle day-to-day fluctuations. This longitudinal study was designed to investigate the pattern of secretion of AMH throughout the menstrual cycle in regularly cycling women. METHODS: Twelve healthy female subjects aged 18-24 years participated in this study. Blood samples were taken every other day throughout one menstrual cycle. Serum FSH, LH, estradiol (E(2)), progesterone, inhibin B and AMH levels were assayed by double-antibody radioimmunoassay using commercial kits. RESULTS: Serum AMH in the first days of the menstrual cycle (days -14 to -12) was 3.8 +/- 1.2 ng/ml (mean +/- SD). No significant changes were observed in serum AMH levels throughout the menstrual cycle. The highest value was 3.9 +/- 1.3 ng/ml at day -12 and the lowest value was 3.4 +/- 1.1 ng/ml at day 14, and the difference was not significant. CONCLUSION: In this study, we demonstrated that serum AMH levels do not change significantly throughout the menstrual cycle. Hence, AMH exhibits a relatively stable expression during the menstrual cycle, making it an attractive determinant of ovarian activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Weenen, C. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah015 · Cited by 1,285
Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary1
Durlinger, A. L. L., Kramer, P., Karels, B., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (1999) · Endocrinology · doi:10.1210/endo.140.12.7204 · Cited by 1,011
Antimüllerian hormone serum levels: a putative marker for ovarian aging
de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02993-4 · Cited by 887
Anti-Müllerian hormone: a new marker for ovarian function
Visser, J. A., de Jong, F. H., Laven, J. S. E., & Themmen, A. P. N. (2006) · Reproduction · doi:10.1530/rep.1.00529 · Cited by 799
Regulation of ovarian function: the role of anti-Mullerian hormone
Durlinger, A. L., Visser, J. A., & Themmen, A. P. (2002) · Reproduction · doi:10.1530/rep.0.1240601 · Cited by 779
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., Rose, U. M., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., et al. (2001) · Endocrinology · doi:10.1210/en.142.11.4891 · Cited by 772
Müllerian-inhibiting substance function during mammalian sexual development
Behringer, R. R., Finegold, M. J., & Cate, R. L. (1994) · Cell · doi:10.1016/0092-8674(94)90251-8 · Cited by 679
van Rooij, I. A. J., Broekmans, F. J. M., Scheffer, G. J., Looman, C. W. N., Habbema, J. D. F., de Jong, F. H., Fauser, B. J. C. M., Themmen, A. P. N., & te Velde, E. R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.029 · Cited by 582
Münsterberg, A., & Lovell-Badge, R. (1991) · Development · doi:10.1242/dev.113.2.613 · Cited by 480
Baarends, W. M., Uilenbroek, J. T., Kramer, P., Hoogerbrugge, J. W., van Leeuwen, E. C., Themmen, A. P., & Grootegoed, J. A. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588229 · Cited by 461
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood
Lee, M. M. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.2.571 · Cited by 431
Rajpert-De Meyts, E., Jørgensen, N., Græm, N., Müller, J., Cate, R. L., & Skakkebæk, N. E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6047 · Cited by 373
La Marca, A., & Volpe, A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02533.x · Cited by 369
Self-citationMullerian Inhibiting Substance: A Gonadal Hormone with Multiple Functions*
LEE, M. M., & DONAHOE, P. K. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-2-152 · Cited by 345
Anti-Müllerian hormone and its receptors
Josso, N., di Clemente, N., & Gouédard, L. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00467-1 · Cited by 308
Rajpert-De Meyts, E. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3836 · Cited by 291
Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition
van Rooij, I. A. J., Tonkelaar, I. D., Broekmans, F. J. M., Looman, C. W. N., Scheffer, G. J., de Jong, F. H., Themmen, A. P. N., & te Velde, E. R. (2004) · Menopause · doi:10.1097/01.gme.0000123642.76105.6e · Cited by 281
Anti-Müllerian hormone and its role in ovarian function
Gruijters, M. J. G., Visser, J. A., Durlinger, A. L. L., & Themmen, A. P. N. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.09.024 · Cited by 238
Serum müllerian-inhibiting substance levels during normal menstrual cycles
Cook, C. L., Siow, Y., Taylor, S., & Fallat, M. E. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00639-1 · Cited by 237
The role of anti-Müllerian hormone in gonadal development
Josso, N., Racine, C., di Clemente, N., Rey, R., & Xavier, F. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00186-5 · Cited by 171
Anti-Müllerian hormone concentrations in maternal serum during pregnancy
La Marca, A., Giulini, S., Orvieto, R., De Leo, V., & Volpe, A. (2005) · Human Reproduction · doi:10.1093/humrep/deh819 · Cited by 160
Self-citationFollicular Depletion during the Menopausal Transition
Richardson, S. J., & Nelson, J. F. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb30312.x · Cited by 140
Serum anti-müllerian hormone levels in women with secondary amenorrhea
Marca, A. L., Pati, M., Orvieto, R., Stabile, G., Artenisio, A. C., & Volpe, A. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.057 · Cited by 114
Self-citationIkeda, Y., Nagai, A., Ikeda, M., & Hayashi, S. (2002) · Endocrinology · doi:10.1210/en.143.1.304 · Cited by 54
Cited by
Ovarian aging: mechanisms and clinical consequences
Broekmans, F. J., Soules, M. R., & Fauser, B. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0006 · Cited by 1,248
The physiology and clinical utility of anti-Müllerian hormone in women
Dewailly, D., Andersen, C. Y., Balen, A., Broekmans, F., Dilaver, N., Fanchin, R., Griesinger, G., Kelsey, T. W., La Marca, A., Lambalk, C., et al. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt062 · Cited by 1,049
Self-citationAnti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
Self-citationTesting and interpreting measures of ovarian reserve: a committee opinion
Penzias, A., Azziz, R., Bendikson, K., Falcone, T., Hansen, K., Hill, M., Hurd, W., Jindal, S., Kalra, S., Mersereau, J., et al. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.09.134 · Cited by 617
Raffi, F., Metwally, M., & Amer, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1558 · Cited by 546
Metadata
- Authors
- La Marca, A., Stabile, G., Artenisio, A. C., & Volpe, A.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-08-21
- Volume
- 21
- Issue
- 12
- Pages
- 3103-3107
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2111770224
- Cited by
- 532
- References
- 25
- FWCI
- 20.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.